Announcements

Dr. Majeed announced the publication of a new book titled “Boswellin®- Anti-Inflammatory Adaptogen from Nature.” Boswellin® range of Boswellia serrata extracts, was introduced by Sami-Sabinsa Group to the nutritional industry in 1990’s. Sami-Sabinsa recognized the unique place of Boswellic acids, the active components of Boswellia, in the firmament of anti-inflammatory agents by their reported LOX inhibition, a subject matter of intense interest in 1990’s that continues even today. Authored by Dr. Majeed, Dr. N. Kalyanam, President, R&D, Sami-Sabinsa and other senior scientists of Sami-Sabinsa Group, this book has tried to capture the quintessential science on Boswellic acids. If the book manages to capture the imagination of the casual reader to get interested in Boswellic acids, the objective of this book is well served!

    VISIT US

  • Edifício Koerich Beiramar Office
    Avenida Mauro Ramos
    1970- Sala 705-Centro
    Florianópolis-SC
    Brasil CEP 88.020-302

  • +55 48 3206 3682
  • info@sabinsa.com.br

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.